REDUCE LAP-HF TRIAL II
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Clinical Trials Related to Heart Failure
Related studies linked through entity extraction aliases.
RESpiration deTection From Implanted Cardiac Devices in Subjects With Heart Failure (REST-HF)
- Status
- UNKNOWN
- Phase
- NA
Characterization of Myocardial Interstitial Fibrosis and Cardiomyocyte Hypertrophy by Cardiac MRI in Heart Failure
- Status
- UNKNOWN
- Phase
- NA
Application of Nanotechnology and Chemical Sensors for Diagnosis of Decompensated Heart Failure by Respiratory Samples
- Status
- UNKNOWN
- Phase
- N/A
A Pivotal Trial to Establish the Efficacy and Safety of Algisyl in Patients With Moderate to Severe Heart Failure
- Status
- UNKNOWN
- Phase
- NA
MAGENTUM 1 HeartMate 3 LVAS: A Single Center Prospective Controlled Study (MAGENTUM 1)
- Status
- UNKNOWN
- Phase
- NA
Global Congestive Heart Failure Registry
- Status
- COMPLETED
- Phase
- N/A
Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry
- Status
- COMPLETED
- Phase
- N/A
Effect of IV Iron in Patients With Heart Failure With Preserved Ejection Fraction
- Status
- COMPLETED
- Phase
- PHASE4
Cardiovascular Imaging and Biomarker Analyses (CIBER)
- Status
- UNKNOWN
- Phase
- N/A
Pericardial Resection to Treat Heart Failure
- Status
- COMPLETED
- Phase
- NA
Use of Simulation to Improve VAD Self-management
- Status
- COMPLETED
- Phase
- NA
Application of Right Atrial Left Ventricular Fusion Pacing in Patients With CRT Indications
- Status
- COMPLETED
- Phase
- NA
Assessment of AAIR Pacing Treatment for Heart Failure Patients With Chronotropic Incompetence
- Status
- COMPLETED
- Phase
- N/A
Respiratory Monitoring During Right Heart
- Status
- UNKNOWN
- Phase
- N/A
Spinal Cord Stimulation in Heart Failure
- Status
- UNKNOWN
- Phase
- NA
Effects of Implementing a High Potassium Diet in Heart Failure Patients
- Status
- COMPLETED
- Phase
- NA
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
- Status
- COMPLETED
- Phase
- PHASE3
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
- Status
- COMPLETED
- Phase
- PHASE3
Day-care Unit for Patients With Refractory Heart Failure
- Status
- UNKNOWN
- Phase
- NA